Movicol

Macrogol 3350 (polyethylene glycol 3350) with electrolytes, the active ingredient in Movicol, is an osmotic laxative presented as a powder for oral solution for oral use. It treats constipation, occasional constipation and fecal impaction in adults and children.

GNH USA supplies Movicol as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol, an osmotic laxative, is used to manage conditions related to reduced bowel motility and stool hardness.

- Constipation: softens stool and facilitates regular bowel movements. - Occasional constipation: relieves infrequent difficulty passing stool. - Fecal impaction: helps to soften impacted stool and promote evacuation.

Common Side Effects: - Abdominal bloating: feeling of fullness or swelling in the abdomen. - Nausea: mild sensation of wanting to vomit. - Flatulence: increased intestinal gas. - Abdominal cramps: intermittent stomach pain. - Diarrhoea: loose, watery stools. - Thirst: increased desire to drink fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal sodium or potassium levels. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe abdominal pain: persistent, intense pain requiring medical attention. - Dehydration: excessive fluid loss leading to dizziness or low blood pressure.

Before using Movicol, consider the following precautions: - Renal function assessment: evaluate kidney health to avoid fluid overload. - Electrolyte monitoring: check sodium and potassium levels during prolonged use. - Elderly patients: use with caution as they may be more susceptible to dehydration. - Bowel obstruction: avoid if a mechanical blockage is suspected. - Dosage adherence: do not exceed the amount prescribed by a healthcare professional. - Store at ambient temperature: keep in the original pack, protect from moisture.

Movicol may interact with other medicines as follows:

Major Interactions (Avoid): - Other osmotic laxatives: combined use can cause severe fluid loss. - Diuretics: may exacerbate electrolyte disturbances. - Magnesium‑containing laxatives: increase risk of dehydration.

Moderate Interactions (Monitor Closely): - Antacids containing aluminium: may reduce laxative effectiveness. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can increase risk of renal impairment. - ACE inhibitors: require monitoring of blood pressure and electrolytes.